NCT06304597RecruitingPhase 1
Evaluating PD-1/PD-L1 in rectal cancer by quantitative fluorescence molecular endoscopy.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 27 Aug 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (estimated)
- First submitted
- 21 Nov 2023
- Start date
- 12 Jan 2026
- Lead sponsor
- Universitair Medisch Centrum Groningen
- Diseases
- Colorectal cancer
- NCT number
- NCT06304597
- EU CT number
- 2023-507106-13-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 23
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Medisch Centrum Groningen Coordinator of this site? Confirm its status | Groningen | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.